10-year, $1B life sciences plan bears fruit in Massachusetts – San Francisco Chronicle
San Francisco Chronicle |
10-year, $1B life sciences plan bears fruit in Massachusetts
San Francisco Chronicle In this Monday, Aug. 14, 2017 photo, researcher Leonard Zon, founder and director of the Stem Cell Program at Boston Children’s Hospital, stands for a photograph among rows of containers holding about 300,00 zebrafish in a lab at the hospital, in Boston. |
MIT Technology Review |
Doctors Plan Bold Test of Gene Therapy on Boys with Muscular Dystrophy
MIT Technology Review Using mini-genes inspired by the man’s genetic defect, three U.S. teams say they are ready to try to treat Duchenne with gene therapy. The first study could begin as soon as next month at Nationwide Children’s Hospital in Columbus, Ohio, with the … |
|
Immunotherapy drug shows favorable safety profile in patients with advanced small cell lung cancer
News-Medical.net The immunotherapy drug pembrolizumab has demonstrated a favorable safety profile and “promising durable clinical activity” in pretreated patients who exhibit high levels of the PD-L1 protein in advanced stages of small cell lung cancer (SCLC) – an … |
|
UQ shares in $13m synthetic biology funding by CSIRO
UQ News Three of 11 nationwide recipients of Future Science Fellows – Dr Konstantinos Vavitsas, Dr Karen Weynberg, and Dr Jason Whitfield – will be hosted at UQ as part of the CSIRO Synthetic Biology Future Science Platform (SynBio FSP). Synthetic biology is a … |
|
UQ shares in $13m synthetic biology funding by CSIRO
UQ News Three of 11 nationwide recipients of Future Science Fellows – Dr Konstantinos Vavitsas, Dr Karen Weynberg, and Dr Jason Whitfield – will be hosted at UQ as part of the CSIRO Synthetic Biology Future Science Platform (SynBio FSP). Synthetic biology is a … |